$QUIT
Achieve Life Sciences, Inc.
Nasdaq · In Vitro & In Vivo Diagnostic Substances · Seattle, WA
QUIT chart
What traders are saying about $QUIT
Latest postsAchieve Life Sciences, Inc. news
- Achieve Life Sciences (QUIT) Stock Price, News & Analysis $QUIT
MarketBeat ·
- Achieve Life Sciences (QUIT) Options Chain & Prices 2026 $QUIT
MarketBeat ·
- Achieve Life Sciences (QUIT) Stock Chart and Price History 2026 $QUIT
MarketBeat ·
- Achieve Life Sciences Reports Q3 2026 Results, $201.5M in Cash
TradingView ·
- QUIT Stock Price and Chart — NASDAQ:QUIT
TradingView ·
- Cash and securities reach $201.5M as the nine-month loss widens at Achieve Life Sciences (ACHV).
Stock Titan ·
- Achieve Life Sciences (ACHV) Stock Price, News & Analysis
Stock Titan ·
- Achieve Life Sciences, Inc. will Change its Ticker to QUIT from ACHV
marketscreener.com ·
- Achieve Life Sciences (NASDAQ:ACHV) Announces Earnings Results
MarketBeat ·
- Total common shares outstanding of Achieve Life Sciences, Inc. – NASDAQ:QUIT
TradingView ·
- Achieve Life Sciences, Inc. Financial Statements – NASDAQ:QUIT
TradingView ·
- Price to book forward of Achieve Life Sciences, Inc. – NASDAQ:QUIT
TradingView ·
Achieve Life Sciences, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | – | – | – | – |
| Net income | -$54.6M | -$39.8M | -$29.8M | -$42.4M |
| Diluted EPS | $-1.25 | $-1.24 | $-1.50 | $-4.00 |
| Total assets (year end) | $41.8M | $38.6M | $19.4M | $30.0M |
| Cash and equivalents (year end) | $20.9M | $12.8M | $15.5M | $24.8M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Achieve Life Sciences, Inc.
- Ticker
- QUIT (Nasdaq)
- Industry
- In Vitro & In Vivo Diagnostic Substances
- Headquarters
- Seattle, WA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 949858
- Former names
- ONCOGENEX PHARMACEUTICALS, INC., SONUS PHARMACEUTICALS INC
Frequently asked questions
What exchange is Achieve Life Sciences, Inc. listed on?
Achieve Life Sciences, Inc. trades on the Nasdaq under the ticker symbol QUIT.
What industry is Achieve Life Sciences, Inc. in?
Achieve Life Sciences, Inc. is classified by the SEC under "In Vitro & In Vivo Diagnostic Substances".
Where is Achieve Life Sciences, Inc. headquartered?
Achieve Life Sciences, Inc.'s business address on file with the SEC is in Seattle, WA.
When does Achieve Life Sciences, Inc.'s fiscal year end?
Achieve Life Sciences, Inc.'s fiscal year ends on December 31.
How much revenue did Achieve Life Sciences, Inc. report?
Achieve Life Sciences, Inc. reported $0 in revenue for calendar year 2019, according to its SEC filings.